Gastric cancer in Jammu and Kashmir, India: A review of genetic perspectives
Journal of Cancer Research and Therapeutics, ISSN: 1998-4138, Vol: 18, Issue: 4, Page: 873-879
2022
- 5Citations
- 9Captures
- 2Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Most Recent News
New Personalized Medicine Study Results from Shri Mata Vaishno Devi University Described (Gastric Cancer In Jammu and Kashmir, India: a Review of Genetic Perspectives)
2022 NOV 07 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Daily -- Investigators discuss new findings in Drugs and Therapies - Personalized
Review Description
Gastric Carcinoma (GC) is one of the most common malignancies, which accounts for 6.8% of total cancer population worldwide. In India, the northeastern region has the highest gastric cancer incidence, and the Kashmir Valley has a very high incidence of gastric cancer as compared to other parts of Northern India. It exceeds 40% of total cancers with an incidence rate of 3-6-fold higher than other metro cities of India. Gastric cancer is a heterogeneous disease where most of the cases are sporadic, and <15% are due to obvious familial clustering. The heterogeneous nature of the disease can be associated with differences in genetic makeup of an individual. A better understanding of genetic predisposition toward GC will be helpful in promoting personalized medicine. The aim of this review is to analyze the development and progression of GC and to explore the genetic perspectives of the disease with special emphasis on Jammu and Kashmir, India.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85103333468&origin=inward; http://dx.doi.org/10.4103/jcrt.jcrt_12_19; http://www.ncbi.nlm.nih.gov/pubmed/33533734; https://journals.lww.com/10.4103/jcrt.JCRT_12_19; https://dx.doi.org/10.4103/jcrt.jcrt_12_19; https://journals.lww.com/cancerjournal/fulltext/2022/18040/gastric_cancer_in_jammu_and_kashmir,_india__a.1.aspx
Medknow
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know